Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001042552 | SCV001206238 | benign | Luscan-Lumish syndrome | 2024-12-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003438653 | SCV004154396 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | SETD2: BP4 |
Ambry Genetics | RCV004958387 | SCV005495666 | likely benign | Inborn genetic diseases | 2024-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004738128 | SCV005362018 | benign | SETD2-related disorder | 2024-08-14 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |